Cartesian Therapeutics Inc

RNAC

Add to Watchlist

9.380USD

+0.540+6.11%

Market hours （ET）Quotes delayed by 15 min

243.91MMarket Cap

LossP/E TTM

Cartesian Therapeutics Inc

9.380

+0.540+6.11%

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Follow the latest Cartesian Therapeutics Inc stock news, earnings, analyst ratings and key developments.

Recent

Cartesian Therapeutics Q2 2026 earnings: R&D spending rises as Phase 3 advances

TradingKey Thu, Aug 6